We've found
1,052
archived clinical trials in
Nephrology
We've found
1,052
archived clinical trials in
Nephrology
Brushite Kidney Stones: A Registry and Database of Clinical and Laboratory Findings
Brushite Stones: A Registry and Database of Clinical and Laboratory Findings
Status: Archived
Brushite Kidney Stones: A Registry and Database of Clinical and Laboratory Findings
Updated: 1/1/1970
Brushite Stones: A Registry and Database of Clinical and Laboratory Findings
Status: Archived
Updated: 1/1/1970
Kidney Stone Structural Analysis By Helical Computed Tomography (CT)
Kidney Stone Structural Analysis by Helical Computed Tomography (A Pilot Study)
Status: Archived
Kidney Stone Structural Analysis By Helical Computed Tomography (CT)
Updated: 1/1/1970
Kidney Stone Structural Analysis by Helical Computed Tomography (A Pilot Study)
Status: Archived
Updated: 1/1/1970
Evaluation of Holotranscobalamin as an Indicator of Vitamin B12 Absorption
Evaluation of Holotranscobalamin as an Indicator of Vitamin B12 Absorption
Status: Archived
Evaluation of Holotranscobalamin as an Indicator of Vitamin B12 Absorption
Updated: 1/1/1970
Evaluation of Holotranscobalamin as an Indicator of Vitamin B12 Absorption
Status: Archived
Updated: 1/1/1970
Effect of Cola on Urinary Stone Risk Factors
Effect of Cola on Urinary Stone Risk Factors
Status: Archived
Effect of Cola on Urinary Stone Risk Factors
Updated: 1/1/1970
Effect of Cola on Urinary Stone Risk Factors
Status: Archived
Updated: 1/1/1970
The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases
The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases. An Observational Biomarker Study
Status: Archived
The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases
Updated: 1/1/1970
The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases. An Observational Biomarker Study
Status: Archived
Updated: 1/1/1970
Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney
Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney (Renal Pelvis)
Status: Archived
Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney
Updated: 1/1/1970
Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney (Renal Pelvis)
Status: Archived
Updated: 1/1/1970
Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney
Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney (Renal Pelvis)
Status: Archived
Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney
Updated: 1/1/1970
Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney (Renal Pelvis)
Status: Archived
Updated: 1/1/1970
Prospective Study Evaluating the Effect of Repository Corticotropin in the Treatment of Various Nephrotic Syndromes
Prospective Study Evaluating the Effect of Repository Corticotropin in the Treatment of Various Nephrotic Syndromes
Status: Archived
Prospective Study Evaluating the Effect of Repository Corticotropin in the Treatment of Various Nephrotic Syndromes
Updated: 1/1/1970
Prospective Study Evaluating the Effect of Repository Corticotropin in the Treatment of Various Nephrotic Syndromes
Status: Archived
Updated: 1/1/1970
Electrohydraulic Versus Laser Lithotripsy
Electrohydraulic Versus Laser Lithotripsy for Difficult to Remove Biliary Stones: A Randomized Study
Status: Archived
Electrohydraulic Versus Laser Lithotripsy
Updated: 1/1/1970
Electrohydraulic Versus Laser Lithotripsy for Difficult to Remove Biliary Stones: A Randomized Study
Status: Archived
Updated: 1/1/1970
Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
A Pilot Study to Evaluate the Effectiveness of a Tenofovir Raltegravir Switch in Resolving Tenofovir Induced Proteinuria in HIV Infected Individuals With Undetectable HIV Viral Loads
Status: Archived
Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
Updated: 1/1/1970
A Pilot Study to Evaluate the Effectiveness of a Tenofovir Raltegravir Switch in Resolving Tenofovir Induced Proteinuria in HIV Infected Individuals With Undetectable HIV Viral Loads
Status: Archived
Updated: 1/1/1970
Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
A Pilot Study to Evaluate the Effectiveness of a Tenofovir Raltegravir Switch in Resolving Tenofovir Induced Proteinuria in HIV Infected Individuals With Undetectable HIV Viral Loads
Status: Archived
Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
Updated: 1/1/1970
A Pilot Study to Evaluate the Effectiveness of a Tenofovir Raltegravir Switch in Resolving Tenofovir Induced Proteinuria in HIV Infected Individuals With Undetectable HIV Viral Loads
Status: Archived
Updated: 1/1/1970
Transversus Abdominus Plane Block
Ultrasound Guided Transversus Abdominus Plane Block for Patients Undergoing Laparoscopic Hand-assisted Nephrectomy.
Status: Archived
Transversus Abdominus Plane Block
Updated: 1/1/1970
Ultrasound Guided Transversus Abdominus Plane Block for Patients Undergoing Laparoscopic Hand-assisted Nephrectomy.
Status: Archived
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Updated: 1/1/1970
Post-Market Observation Study of Intra-Renal Drug Delivery (PROVIDE)
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Febuxostat Versus Allopurinol or Placebo in Subjects With Hyperuricosuria and Calcium Oxalate Stones
Updated: 1/1/1970
A Multicenter, Randomized, Double-Blind, Placebo and Allopurinol Controlled, Phase 2 Study to Evaluate Febuxostat in the Medical Management of Subjects With Hyperuricosuria and Calcium Oxalate Stones
Status: Archived
Updated: 1/1/1970
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
Updated: 1/1/1970
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
Updated: 1/1/1970
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
Updated: 1/1/1970
A Phase IIa, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability and Clinical Effect of Laquinimod in Active Lupus Nephritis Patients, in Combination With Standard of Care (Mycophenolate Mofetil and Steroids)
Status: Archived
Updated: 1/1/1970